tiprankstipranks
Advertisement
Advertisement

Skin Elements refreshes board as it shifts from R&D to commercial rollout

Story Highlights
  • Skin Elements has appointed Rod Nicholas and Joshua Gordon as non-executive directors while Stuart Usher retires from the board but remains company secretary.
  • The board refresh is intended to support Skin Elements’ shift from research and development to commercial operations and strengthen its growth and market positioning.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Skin Elements refreshes board as it shifts from R&D to commercial rollout

Claim 55% Off TipRanks

Skin Elements Limited ( (AU:SKN) ) just unveiled an update.

Skin Elements Limited has strengthened its board with the appointment of Rod Nicholas and Joshua Gordon as non-executive directors, effective 24 February 2026, while long-serving non-executive director Stuart Usher retires from the board but remains as company secretary. Chairman and CEO Peter Malone said the timing of the new appointments aligns with the company’s transition from a research and development focus to full commercial operations, signalling a more commercially driven phase for the business and potentially enhancing its capital markets engagement.

These changes bring extensive commercial, retail, financial services, and ASX corporate finance expertise onto the board, with Nicholas a significant shareholder and seasoned executive, and Gordon currently a corporate finance director and non-executive director at other ASX-listed companies. The refreshed board composition is expected to support Skin Elements’ efforts to scale its plant-based biotechnology product portfolio and strengthen its positioning in both domestic and global markets as it moves into its next stage of growth.

The most recent analyst rating on (AU:SKN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Skin Elements Limited stock, see the AU:SKN Stock Forecast page.

More about Skin Elements Limited

Skin Elements Limited is an Australian-owned, ASX-listed natural biotechnology company focused on developing its SE Formula Biotechnology using plant-based and organically sourced ingredients. The company has created five all-natural formulations with global applications, including the SuprCuvr hospital-grade plant-based disinfectant, ECO-Nurture plant bio-stimulant, Soléo Organics natural sunscreen, PapayaActivs therapeutic skincare, and the Elizabeth Jane Natural Cosmetics brand.

Current Market Cap: A$12M

For a thorough assessment of SKN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1